Preclinical evaluation of PARP inhibitors in combination with DNA-damaging agents in a Ewing sarcoma orthotopic xenograft model.
Elizabeth Stewart
No relevant relationships to disclose
David Ross Goshorn
No relevant relationships to disclose
Michael A. Dyer
No relevant relationships to disclose
Anang Shelat
No relevant relationships to disclose
Cori Bradley
No relevant relationships to disclose
Alberto S. Pappo
No relevant relationships to disclose
Amos Loh
No relevant relationships to disclose